TY - JOUR
T1 - Incorporation of Nonmethyl Branches by Isoprenoid-like Logic
T2 - Multiple β-Alkylation Events in the Biosynthesis of Myxovirescin A1
AU - Calderone, Christopher T.
AU - Iwig, David F.
AU - Dorrestein, Pieter C.
AU - Kelleher, Neil L.
AU - Walsh, Christopher T.
N1 - Funding Information:
This work was supported by National Institutes of Health (NIH) postdoctoral fellowships to C.T.C. (GM081743) and P.C.D. (GM073323), NIH grants to N.L.K. (GM067725) and C.T.W. (AI042738 and GM020011), and a generous grant to N.L.K. from The David and Lucille Packard Foundation.
PY - 2007/7/30
Y1 - 2007/7/30
N2 - Several polyketide secondary metabolites are predicted to undergo isoprenoid-like β-alkylations during biosynthesis. One such secondary metabolite is myxovirescin A1, produced by Myxococcus xanthus. Myxovirescin is of special interest in that it appears to undergo two distinct β-alkylations. Additionally, the myxovirescin biosynthetic gene cluster lacks tandem thiolation domains required in the synthesis of other β-branched secondary metabolites. To probe the origins of the β-branches in myxovirescin, we heterologously overexpressed the proteins predicted to be responsible for myxovirescin β-alkylation and reconstituted their activities in vitro on model substrates. Our results confirm that myxovirescin undergoes two isoprenoid-like β-alkylations during its biosynthesis, including an unprecedented β-ethylation. The study of its biosynthesis should shed light on the scope and requirements for isoprenoid-like biosynthetic logic in a polyketide context.
AB - Several polyketide secondary metabolites are predicted to undergo isoprenoid-like β-alkylations during biosynthesis. One such secondary metabolite is myxovirescin A1, produced by Myxococcus xanthus. Myxovirescin is of special interest in that it appears to undergo two distinct β-alkylations. Additionally, the myxovirescin biosynthetic gene cluster lacks tandem thiolation domains required in the synthesis of other β-branched secondary metabolites. To probe the origins of the β-branches in myxovirescin, we heterologously overexpressed the proteins predicted to be responsible for myxovirescin β-alkylation and reconstituted their activities in vitro on model substrates. Our results confirm that myxovirescin undergoes two isoprenoid-like β-alkylations during its biosynthesis, including an unprecedented β-ethylation. The study of its biosynthesis should shed light on the scope and requirements for isoprenoid-like biosynthetic logic in a polyketide context.
KW - CHEMBIOL
KW - MICROBIO
UR - http://www.scopus.com/inward/record.url?scp=34447535180&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34447535180&partnerID=8YFLogxK
U2 - 10.1016/j.chembiol.2007.06.008
DO - 10.1016/j.chembiol.2007.06.008
M3 - Article
C2 - 17656320
AN - SCOPUS:34447535180
SN - 1074-5521
VL - 14
SP - 835
EP - 846
JO - Chemistry and Biology
JF - Chemistry and Biology
IS - 7
ER -